Zambrotta GPM, Nicolini FE, Assouline S, Busque L, et al. Risk of progression in chronic phase-chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR-PRO study. Am J Hematol 2023 Aug 30. doi: 10.1002/ajh.27073.
PMID: 37647134